CIK 0001509261
- Non-accelerated filer
- Smaller reporting company
Rezolute, Inc.
Sign in to watch- Ticker
- RZLT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Jun 30
- Incorporated
- NV
- Entity type
- Operating
- EIN
- 273440894
- Phone
- +1 650-206-4507
- Business address
- 275 SHORELINE DRIVE, SUITE 500, REDWOOD CITY, CA, 94065
- Former names
- AntriaBio, Inc., FITS MY STYLE INC
- 4 Open-market buy CFO bought 20,000 shares at an average $2.89 ($57,700)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy Director bought 10,000 shares at $4.70 ($47,000)
- 4 Grant or award Director acquired 25,500 shares (grant or award)
- 4 Grant or award CFO acquired 77,000 shares (grant or award)
- 4 Grant or award Director acquired 25,500 shares (grant or award)
- 4 Open-market buy Director bought 1,250,000 shares at $4.00 ($5,000,000)
- 4 Grant or award Chief Medical Officer acquired 77,000 shares (grant or award)
- 4 Grant or award CEO acquired 204,000 shares (grant or award)
- 4 Grant or award Director acquired 25,500 shares (grant or award)
- 4 Open-market buy CFO bought 10,000 shares at $4.29 ($42,900)
- 4 Open-market buy CFO bought 9,000 shares at $4.60 ($41,400)
- 4 Open-market buy CFO bought 10,549 shares at $5.04 ($53,167)
- 4 Open-market buy Director bought 4,259 shares at $4.70 ($20,017)
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Director bought 4,815 shares at $4.15 ($19,982)
- 4 Open-market buy Chief Medical Officer bought 7,600 shares at an average $3.91 ($29,743)
- 4 Open-market buy CFO bought 40,000 shares at $4.04 ($161,568)
- 4 Open-market buy CFO bought 451 shares at $3.50 ($1,579)
Page 3 of 11 · 208 filings